GL1X · GenesisL1 explorer

MolNFT v1 · #149372 · protein

X-ray structure of CLK2-KD(136-496)/INDAZOLE1 at 2.39A

6FYK · Dual specificity protein kinase CLK2: “X-ray structure of CLK2-KD(136-496)/INDAZOLE1 at 2.39A”. X-ray diffraction, 1 ligand (EAZ), 8 pockets (best druggability 0.78). MolNFT v1 #149372 on GenesisL1: 3D structure, binding sites and…

PDB
6FYK
Type
protein
Length
1,047 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity protein kinase CLK2
EC
2.7.12.1
UniProt
P49760
Ligands
EAZ
Pockets
8 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CDual specificity protein kinase CLK2 (EC 2.7.12.1)protein34938% helix, 20% strandP49760

Ligands and binding sites

  • EAZ · (2~{S})-4-methyl-1-[5-(3-methyl-2~{H}-indazol-5-yl) pyridin-3-yl]oxy-pentan-2-amine · ligand · 3 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17570.780.8284empty
24230.650.7846EAZ
32630.640.8124EAZ
42890.640.8028EAZ
53490.640.7946empty

Interfaces

3 interfaces between chains.

  • A–B · 618 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 185 Ų buried · 0 hydrogen bonds · protein-protein
  • B–C · 125 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 6FYK · X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A · the same entry in another collection · chain A against A, TM-score 1.00
  • P49760 · AlphaFold monomer V2.0 prediction for dual specificity protein kinase CLK2 (P49760) · a predicted model of the same protein · chain C against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.